0B68 Ciric, Bogoljub - Thomas Jefferson University - Thomas Jefferson University
Bogoljub Ciric, PhD

Bogoljub Ciric, PhD

Contact Dr.  Ciric

901 Walnut Street
Suite 400
Philadelphia, PA 19107

(215) 955-9425

Most Recent Peer-reviewed Publications

  1. Neural Stem Cells Engineered to Express Three Therapeutic Factors Mediate Recovery from Chronic Stage CNS Autoimmunity
  2. 1C84
  3. Galectin-1 is essential for the induction of MOG35–55-based intravenous tolerance in experimental autoimmune encephalomyelitis
  4. LINGO-1-Fc-Transduced Neural Stem Cells Are Effective Therapy for Chronic Stage Experimental Autoimmune Encephalomyelitis
  5. IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis
  6. IL-9 signaling affects central nervous system resident cells during inflammatory stimuli
  7. Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway
  8. Emerging immunopharmacological targets in multiple sclerosis
  9. 1,25-Dihydroxyvitamin D3 enhances neural stem cell proliferation and oligodendrocyte differentiation
  10. Expression of GM-CSF in T cells is increased in multiple sclerosis and suppressed by IFN-β therapy
  11. Silencing IFN-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity
  12. Astrocyte-derived lactosylceramide implicated in multiple sclerosis
  13. Tolerogenic dendritic cells produced by lentiviral-mediated CD40- and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cells
  14. Neurotrophin 3 transduction augments remyelinating and immunomodulatory capacity of neural stem cells
  15. Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis
  16. Committed Tc17 cells are phenotypically and functionally resistant to the effects of IL-27
  17. Erratum: CNS-specific Therapy for Ongoing EAE by Silencing IL-17 Pathway in Astrocytes(Molecular Therapy)
  18. GM-CSF in autoimmune inflammation of the central nervous system
  19. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination
  20. Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity
  21. Immune tolerance induced by intravenous transfer of immature dendritic cells via up-regulating numbers of suppressive IL-10+ IFN-γ+-producing CD4+ T cells
0